Prescribing antibiotics for patients with discoloured phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery, a Cardiff University study has found.
Acute cough is one of the common reasons why people visit their general practitioner (GP) and accounts for a large proportion of antibiotics prescribed in the community. One of the most common questions asked by GPs to their patients is about their phlegm: "Are you coughing anything up?" or "What color is your phlegm?"
Clinicians and patients commonly believe that yellow and green phlegm production is associated with a bacterial infection, which is more likely to benefit from antibiotic treatment compared to non-productive cough or cough that produces clear phlegm.
However, in a new study published in the European Respiratory Journal, professor Chris Butler and his team from Cardiff University's School of Medicine, together with colleagues from 14 European centers present data from an observational study of 3,402 adult patients with acute cough presenting for healthcare in 14 primary care networks.
The research found that patients producing discolored phlegm are prescribed antibiotics more frequently than those not producing phlegm unlike those producing clear/white phlegm.
Crucially, antibiotic treatment was not associated with greater rate or magnitude of symptoms score resolution among those who produced yellow or green phlegm. Neither was recovery among those feeling generally unwell on its own, or taken together with phlegm production, associated with antibiotic treatment.
Clinicians and patients are therefore likely to both be over interpreting the importance of the color of phlegm in the decision whether or not to prescribe, or take, antibiotics.
Butler, who led the study, says, "One of the exciting things about this research is that our findings from this large, multi-country observational study resonate with findings from randomized trials where benefit from antibiotic treatment in those producing discolored phlegm has been found to be marginal at best or non-existent. Our findings add weight to the message that acute cough in otherwise well adults is a self-limiting condition and antibiotic treatment does not speed recovery to any meaningful extent. In fact, antibiotic prescribing in this situation simply unnecessarily exposes people to side effects from antibiotics, undermines future self care, and drives up antibiotic resistance."
A single center study, using different research methods, by one of Butler's predecessors at Cardiff University, reached similar conclusions to this new research. Despite this, non-evidence based practice remains common across the UK.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.